TP53 gene expression levels and tumor aggressiveness in canine mammary carcinomas

被引:11
作者
Oliveira, Taya F. [1 ]
Maues, Tabata [1 ]
Ramundo, Mariana S. [3 ]
Figueiredo, Agnes Marie S. [3 ]
de Mello, Marcela F. V. [2 ]
El-Jaick, Kenia B. [4 ]
Ferreira, Maria de Lourdes G. [1 ]
Ferreira, Ana Maria R. [2 ]
机构
[1] Univ Fed Fluminense, Dept Clin Vet, BR-24230340 Niteroi, RJ, Brazil
[2] Univ Fed Fluminense, Dept Anat Pathol, Niteroi, RJ, Brazil
[3] Univ Fed Rio de Janeiro, Dept Med Microbiol, Rio De Janeiro, RJ, Brazil
[4] Univ Fed Estado Rio de Janeiro, Dept Genet & Mol Biol, Rio De Janeiro, RJ, Brazil
关键词
Dogs; mammary neoplasms; messenger RNA; p53; gene; real-time PCR; tumor suppressor gene; tumor suppressor protein p53; P53;
D O I
10.1177/1040638717721730
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The protein p53 is considered to be one of the most important tumor suppressor factors. Despite this importance, a potential association between TP53 messenger (m)RNA levels and tumor aggressiveness has not been well defined in animal cancer. We assessed and correlated TP53 gene expression in 40 canine mammary carcinomas with histologic grade, tumor size, and aggressiveness. The tumors were subjected to histologic analysis and the TP53 mRNA levels determined by RT-rtPCR. Statistical analysis revealed no correlation between levels of TP53 mRNA and tumor aggressiveness (r = 0.00) or tumor growth (r = 0.06). Histologic grades (r = 0.17) and mitosis count (r = 0.12) showed a weak correlation with TP53 mRNA expression levels. These findings are consistent with molecular studies that revealed heterogeneous expression of TP53 in canine and human mammary tumors. Hence, TP53 gene expression alone cannot be considered a marker for tumor aggressiveness in canine mammary carcinomas.
引用
收藏
页码:865 / 868
页数:4
相关论文
共 10 条
[1]   Deconstructing p53 transcriptional networks in tumor suppression [J].
Bieging, Kathryn T. ;
Attardi, Laura D. .
TRENDS IN CELL BIOLOGY, 2012, 22 (02) :97-106
[2]  
Cassali G. D., 2014, Brazilian Journal of Veterinary Pathology, V7, P38
[3]   Potential markers for detection of circulating canine mammary tumor cells in the peripheral blood [J].
da Costa, A. ;
Oliveira, J. T. ;
Gaertner, F. ;
Kohn, B. ;
Gruber, A. D. ;
Klopfleisch, R. .
VETERINARY JOURNAL, 2011, 190 (01) :165-168
[4]  
Elston C W, 1998, Clin Oncol (R Coll Radiol), V10, P14, DOI 10.1016/S0936-6555(98)80105-2
[5]   Association between Mutation and Expression of TP53 as a Potential Prognostic Marker of Triple-Negative Breast Cancer [J].
Kim, Ji-Yeon ;
Park, Kyunghee ;
Jung, Hae Hyun ;
Lee, Eunjin ;
Cho, Eun Yoon ;
Lee, Kwang Hee ;
Bae, Soo Youn ;
Lee, Se Kyung ;
Kim, Seok Won ;
Lee, Jeong Eon ;
Nam, Seok Jin ;
Ahn, Jin Seok ;
Im, Young-Hyuck ;
Park, Yeon Hee .
CANCER RESEARCH AND TREATMENT, 2016, 48 (04) :1338-1350
[6]   The Combined Expression Pattern of BMP2, LTBP4, and DERL1 Discriminates Malignant From Benign Canine Mammary Tumors [J].
Klopfleisch, R. ;
Klose, P. ;
Gruber, A. D. .
VETERINARY PATHOLOGY, 2010, 47 (03) :446-454
[7]   Differential expression of cell cycle regulators p21, p27 and p53 in metastasizing canine mammary adenocarcinomas versus normal mammary glands [J].
Klopfleisch, R. ;
Gruber, A. D. .
RESEARCH IN VETERINARY SCIENCE, 2009, 87 (01) :91-96
[8]   Of humans and canines:: Immunohistochemical analysis of PCNA, Bcl-2, p53, cytokeratin and ER in mammary tumours [J].
Kumaraguruparan, R. ;
Prathiba, D. ;
Nagini, S. .
RESEARCH IN VETERINARY SCIENCE, 2006, 81 (02) :218-224
[9]   Aberrations of the p53 tumor suppressor gene in various tumors in dogs [J].
Setoguchi, A ;
Sakai, T ;
Okuda, M ;
Minehata, K ;
Yazawa, M ;
Ishizaka, T ;
Watari, T ;
Nishimura, R ;
Sasaki, N ;
Hasegawa, A ;
Tsujimoto, H .
AMERICAN JOURNAL OF VETERINARY RESEARCH, 2001, 62 (03) :433-439
[10]   Only Missense Mutations Affecting the DNA Binding Domain of P53 Influence Outcomes in Patients with Breast Carcinoma [J].
Vegran, Frederique ;
Rebucci, Magali ;
Chevrier, Sandy ;
Cadouot, Muriel ;
Boidot, Romain ;
Lizard-Nacol, Sarab .
PLOS ONE, 2013, 8 (01)